40 women were treated for uncomplicated genital gonorrhoea, verified by culture, with a single oral dose of 1,200 mg rifampicin (Rimactan). The ages ranged between 15 and 51 years. In 33 patients that could be evaluated, the gonorrhoea was cured. In 8 of 18 patients the preexistent vaginal discharge improved. 4 women experienced six different side effects which were probably related to rifampicin. The 1,200-mg rifampicin oral one-dose treatment is a reliable, efficient, and well-tolerated therapy of uncomplicated gonorrhoea in women.

Download full-text PDF

Source

Publication Analysis

Top Keywords

oral one-dose
8
one-dose treatment
8
[1200 rifampicinrimactan
4
rifampicinrimactan oral
4
treatment uncomplicated
4
uncomplicated gonorrhea
4
gonorrhea women]
4
women] women
4
women treated
4
treated uncomplicated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!